Syntheses and biological evaluation of new glyco-modified angucyclin-antibiotics

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 9, 2000, Pages 2347-2354

  Kirschning, Andreas ^a   Chen, Guang Wu ^a   Dräger, Gerald ^a   Schuberth, Ingrid ^b   Tietze, Lutz F ^b  

^a CLAUSTHAL UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3' (2'',6'' DIDEOXYARABINOSYLOXY)AQUAYAMYCIN; 4' (2'',6'' DIDEOXYARABINOSYL)AQUAYAMYCIN; ALLOPURINOL; ANGUCYCLINE DERIVATIVE; ANTIBIOTIC AGENT; AQUAYAMYCIN; CYTOTOXIC AGENT; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; GLYCOSYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; TUMOR CELL LINE;

ANIMALS; ANTHRAQUINONES; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; BENZ(A)ANTHRACENES; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLYCOSIDES; HUMANS; MICE; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACYCLINES; TUMOR CELLS, CULTURED; XANTHINE OXIDASE;

EID: 0033898083     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00166-8     Document Type: Article

References (53)

1. (a) Krohn, K.; Rohr, J. Top. Curr. Chem. 1997, 188, 127.
2. (b) Rohr, J.; Thiericke, R. Nat. Prod. Rep. 1992, 9, 103.
3. (c) Thomson, R. H. In Naturally Occurring Quinones III. Recent Advances; Chapman and Hall: London, 1987.
4. (a) Dann, M.; Lefemine, D. V.; Barbatschi, F.; Shu, P.; Kunstmann, M. P.; Mitscher, L. A.; Bohonos, N. Antimicrob. Agents Chemother. 1965, 832.
5. (b) Kunstmann, M. P.; Mitscher, L. A. J. Org. Chem. 1966, 31, 2920.
6. Crooke, S. T.; Reich, S. D., Eds.; Anthracyclines - Current Status and Developments; Academic: Orlando, 1980.
7. Other important 2,3,6-trideoxysugars present in angucycline antibiotics are L-aculose, L-cinerulose, D-kerriose, D-amicetose and D-rhodinose.
8. Reviews: (a) Hermann, T.; Westhof, E. Curr. Opin. Biotechnol. 1998, 9, 66.
9. (b) Michael, K.; Tor, Y. Chem. Eu. J. 1998, 4, 2091.
10. (c) Pearson, N. D.; Prescott, C. D. Chem. Biol. 1997, 4, 409.
11. (d) Lown, S. J. In Anthracycline and Anthracenedione-Based Anticancer Agents; 1988; Section 2 (Bioact. Mol. 1988, 6).
12. (d) Lown, S. J. In Anthracycline and Anthracenedione-Based Anticancer Agents; 1988; Section 2 (Bioact. Mol. 1988, 6).
13. An excellent review, describing the factors which are important for cooperative effects in biological systems, was published by: Mammen, M.; Choi, S. K.; Whitesides, G. M. Angew. Chem. 1998, 110, 2908; Angew. Chem., Int. Ed. Engl. 1998, 37, 2754.
14. An excellent review, describing the factors which are important for cooperative effects in biological systems, was published by: Mammen, M.; Choi, S. K.; Whitesides, G. M. Angew. Chem. 1998, 110, 2908; Angew. Chem., Int. Ed. Engl. 1998, 37, 2754.
15. (a) Kirschning, A.; Rohr, J.; Bechtold, A. Top. Curr. Chem. 1997, 188, 1.
16. (b) Gilbert, D. E.; Feigon, J. Curr. Opin. Struct. Biol. 1991, 1, 439.
17. Gräfe, U. Biochemie der Antibiotika: Struktur, Biosynthese, Wirkmechanismus. Spektrum Akademischer Verlag: Heidelberg, Berlin, New York, 1992.
18. (a) Malabarba, A.; Nicas, T. I.; Thompson, R. C. Med. Res. Rev. 1997, 17, 69.
19. (b) Nagarajan R., Schabel A.A., Occolowitz J.L., Counter F.T., Ott J.L., Felty-Duckworth A.M. J. Antibiotics 1989, 42, 63.
20. (c) Nagarajan, R. J. Antibiotics 1993, 46, 1181.
21. (d) Rodriguez, M. J.; Snyder, N. J.; Zweifel, M. J.; Wilkie, S. C.; Stack, D. R.; Cooper, R. D.; Nicas, T. I.; Mullen, D. L.; Butler, T. F.; Thompson, R. C. J. Antibiotics 1998, 51, 560.
22. Elegant total syntheses of angucycline antibiotics: (a) Matsuo, G.; Miki, Y.; Nakata, M.; Matsumura, S.; Toshima, K. J. Chem. Soc., Chem. Commun. 1996, 225.
23. (b) Matsumoto, T.; Sohma, T.; Yamaguchi, H.; Kurata, S.; Suzuki, K. Synlett 1995, 263.
24. (c) Kim, K.; Sulikowski, G. A. Angew. Chem. 1995, 107, 2587; Angew. Chem., Int. Ed. Engl. 1995, 34, 2396.
25. (c) Kim, K.; Sulikowski, G. A. Angew. Chem. 1995, 107, 2587; Angew. Chem., Int. Ed. Engl. 1995, 34, 2396.
26. (d) Krohn, K.; Khanbabaee K. Liebigs Ann. Chem. 1994, 1109.
27. (e) Yamaguchi, M.; Okuma, T.; Horiguchi, A.; Ikeura, C.; Minami, T. J. Org. Chem. 1992, 57, 1647.
28. Couplings of glycals with anthracyclinones have been studied by: (a) Roche, C. J.; Berkowitz, D.; Sulikowski, G. A.; Danishefsky, S. J.; Crothers, D. M. Biochemistry 1994, 33, 936.
29. (b) Berkowitz, D. B.; Danishefsky, S. J.; Schulte, G. K. J. Am. Chem. Soc. 1992, 114, 4518.
30. (c) Suzuki, K.; Sulikowski, G. A.; Friesen, R. W.; Danishefsky, S. J. J. Am. Chem. Soc. 1990, 112, 8895.
31. (d) Thiem, J.; Klaffke, W. J. Org. Chem. 1989, 54, 2006.
32. Sezaki M., Kondo S., Maeda K., Umezawa H., Ohno M. Tetrahedron. 26:1970;5171.
33. (a) Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem. 1996, 108, 1482; Angew. Chem., Int. Ed. Engl. 1996, 35, 1380.
34. (a) Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem. 1996, 108, 1482; Angew. Chem., Int. Ed. Engl. 1996, 35, 1380.
35. (b) Danishefsky, S. J.; Roberge, J. Y. Pure Appl. Chem. 1995, 67, 1647.
36. Dräger G., Garming A., Maul C., Noltemeyer M., Thiericke R., Zerlin M., Kirschning A. Chem. Eu. J. 4:1998;1324.
37. (a) Drautz, H.; Zähner, H.; Rohr, J.; Zeeck, A. J. Antibiot. 1986, 39, 1657.
38. (b) Zeeck, A.; Rohr, J.; Sheldrick, G. M.; Jones, P. G.; Paulus, E. F. J. Chem. Res. (S) 1986, 104.
39. Rohr, J., PhD dissertation, University of Göttingen 1984.
40. 2:MeOH 9:1 then Sephadex: MeOH, pH 7).
41. Perez M., Beau J.-M. Tetrahedron Lett. 30:1989;75.
42. Dräger, G., PhD dissertation, TU Clausthal 1997.
43. The preparation of both enantiomers of 10 has been reported in refs 8a and e and in: Boyd, V. A.; Sulikowski, G. A. J. Am. Chem. Soc. 1995, 117, 8472.
44. (a) Toshima, K.; Tatsuta, K.; Kinoshita, M. Bull. Chem. Soc. Jpn. 1988, 61, 2369.
45. (b) Tatsuta, K.; Kobayashi, H.; Gunji, H.; Masuda, H. Tetrahedron Lett. 1988, 29, 3975.
46. Bolitt V., Mioskowski C., Lee S.-G., Falck J.R. J. Org. Chem. 55:1990;5812.
47. Krohn K., Bäuerlein C. J. Carbohydr. Chem. 18:1999;807.
48. Tietze, L. F.; Hannemann, R.; Buhr, W.; Lögers, M.; Menningen, P.; Lieb, M.; Starck, D.; Grote, T.; Döring, A.; Schuberth, I. Angew. Chem. 1996, 108, 2840; Angew. Chem., Int. Ed. Engl. 1996, 35, 2674.
49. Tietze, L. F.; Hannemann, R.; Buhr, W.; Lögers, M.; Menningen, P.; Lieb, M.; Starck, D.; Grote, T.; Döring, A.; Schuberth, I. Angew. Chem. 1996, 108, 2840; Angew. Chem., Int. Ed. Engl. 1996, 35, 2674.
50. 50 is determined as the effective dose giving 50% growth inhibition.
51. The tests have been conducted at the Hans-Knöll-Institut in Jena, Germany.
52. Härtl A., Stelzner A., Ritzau M., Heinze S., Gräfe U. J. Antibiotics. 51:1998;528.
53. Härtl, A.; Sattler, I. (Hans-Knöll-Institut in Jena, Germany), private communication.